Organon & Co. Common Stock OGN 深 沪
等待开盘 10-02 09:30:00 美东时间
10.99
+0.310
+2.90%
华盛通- 最 高11.15
- 今 开10.68
- 成交量 440.12万股
- 最 低 10.68
- 昨 收 10.68
- 总市值 28.57亿
- 52周最高 18.445
- 市盈率 静 3.30
- 换手率 1.69%
- 52周最低 7.99
- 委 比 -53.30%
- 总股本 2.60亿
- 历史最高 36.075
- 量 比 1.50
- 振 幅 4.40%
- 历史最低 7.99
- 每 手 1
- 风险率 2.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Origin Enterprises Transfers Treasury Shares to Satisfy Share Options
An announcement from Origin Enterprises plc ( ($GB:OGN) ) is now available. Ori...
10-01 20:17
Orion Group Holdings Announces the Appointment of Robert Ledford to its Board of Directors
Orion Group Holdings, Inc. announced the appointment of Robert (Bob) Ledford to its Board of Directors effective November 19, 2025. Travis Boone, President and CEO, highlighted Ledford's extensive leadership in construction and engineering, financial expertise, and track record in driving growth through mergers and acquisitions. Ledford brings over 35 years of experience, including roles at Prime Electric and AECOM. He will join Orion's Board, ex...
09-29 12:57
Protector Forsikring ASA Reduces Stake in Origin Enterprises
Origin Enterprises plc ( ($GB:OGN) ) has issued an update. Origin Enterprises p...
09-25 23:07
辅助生殖告别注射时代！全球首个口服GnRH拮抗剂上市在即，恒瑞挑战辅助生殖百亿市场！
（来源：求实药社） 2025年9月23日，恒瑞医药发布公告称，其自主研发的1类创新药SHR7280片的药品上市许可申请获受理。该药物拟定适应症为“在辅助生殖技术...
09-25 11:57
Orogen Royalties Announces Significant Exploration Updates and New Alliances
The latest update is out from Orogen Royalties ( ($TSE:OGN) ). Orogen Royalties...
09-24 20:10
Origin Enterprises plc Announces Grant of Options to CFO
Origin Enterprises plc ( ($GB:OGN) ) just unveiled an announcement. Origin Ente...
09-24 17:02
港股早知道 | 香港宽频获控股股东中移香港拟配售公司现有股份；信达生物玛仕度肽获批糖尿病适应症
香港宽频获控股股东中移香港拟配售公司现有股份；信达生物玛仕度肽获批糖尿病适应症；地平线机器人明年发布并争取量产舱驾一体芯片>>
09-22 07:51
美欧双批！复宏汉霖两款地舒单抗再获欧盟批准
复宏汉霖(2696.HK)与Organon(OGN.US)今日联合宣布，欧盟委员会已批准地舒单抗注射液(60 mg/mL)BILDYOS®(denosumab...
09-19 18:59
复宏汉霖(02696.HK)：欧盟委员会批准 HLX14(地舒单抗)两个产品用于特定人群骨质疏松症治疗等适应症
复宏汉霖(02696.HK)发布公告，近日，BILDYOS以及BILPREVDA 两个产品的上市许可申请(MAAs)已获欧盟委员会(European Commission， EC)批准，该等商品名由N.V. Organon于欧盟注册商标。此次获批意味着 BILDYOS及BILPREVDA在所有欧盟成员国及冰岛、列支敦士登和挪威(各自为欧洲经济区(EEA)国家)获得集中上市许可。
09-19 18:00
Orogen Royalties Commences Trading on OTCQB Market
Orogen Royalties ( ($TSE:OGN) ) just unveiled an update. Orogen Royalties Inc. ...
09-08 20:19
